FDA Inspection
Rockefeller Fertility CenterRockefeller Fertility Center – FDA Inspection, Jul 30, 2026
Record Details
This FDA Inspection record concerns Rockefeller Fertility Center, with an inspection on July 30, 2026, issued by the New York District Office, covering biologics.
View Company Profile
ID · 58652d6a-dffb-429c-b276-a4c69a28b954
Inspection Facts
- Inspection number
- 1328744
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.50(a)Determination based on screening and testing
- 21 CFR 1271.55(d)(2)Accurate, indelible, legible
- 21 CFR 1271.90(c)Eligibility not required--warning labels
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rockefeller Fertility Center
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 9, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 5, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Rockefeller Fertility Center
- FDA Inspection 1193261 - 2022-12-09
- FDA Inspection 1155993 - 2021-11-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.